Page last updated: 2024-11-05

tyramine and Bladder Cancer

tyramine has been researched along with Bladder Cancer in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Thus, CpdA likely inhibits bladder cancer growth predominantly via inducing GR transrepression and at least partially mediated through the AR pathway, suggesting its effects more beneficial than GCs/pure GR ligands or AR antagonists."1.42Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression. ( Ide, H; Inoue, S; Ishiguro, H; Jalalizadeh, M; Kashiwagi, E; Kawahara, T; Miyamoto, H; Reis, LO; Zheng, Y, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, Y1
Ishiguro, H1
Ide, H1
Inoue, S1
Kashiwagi, E1
Kawahara, T1
Jalalizadeh, M1
Reis, LO1
Miyamoto, H1
Kaufmann, O1
Baume, H1
Dietel, M1
Lachhein, L1
Schütz, J1

Reviews

1 review available for tyramine and Bladder Cancer

ArticleYear
[Possibilities and limitations in the diagnosis of pheochromocytoma].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1969, May-01, Volume: 24, Issue:9

    Topics: Adrenal Gland Neoplasms; Blood Pressure; Catecholamines; Chromatography; Epinephrine; Histamine; Hum

1969

Other Studies

2 other studies available for tyramine and Bladder Cancer

ArticleYear
Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Molecular endocrinology (Baltimore, Md.), 2015, Volume: 29, Issue:10

    Topics: Acetates; Androgen Antagonists; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation

2015
Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.
    The Journal of pathology, 1998, Volume: 186, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biotin; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme T

1998